Further positive data for Mologic COVID-19 lateral flow antigen test
Omega Diagnostics Gp (ODX.L) Positive data for Mologic COVID-19 antigen test
Omega Diagnostics Gp (ODX.L) Launch of VISITECT® COVID-19 Antigen & Update
Rapid diagnostic test for visual detection of SARS-CoV-2 antigen
Omega Diagnostics Gp (ODX.L) CE-Mark: Mologic COVID19 lateral flow antigen test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that it has CE-Marked Mologic Ltd’s (‘Mologic’) lateral flow antigen test for COVID-19, to
Omega Diagnostics Gp (ODX.L) UK Public Sector Contract disclosure
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, announces that a UK Public Sector contract disclosure has been published yesterday in relation to
Omega Diagnostics Gp (ODX.L) Contract with Screen4
Contract with Screen4 for COVID-19 antibody laboratory-based testing service
Omega Diagnostics Gp (ODX.L) UK-RTC statement on AbC-19TM rapid antibody test
Lateral flow test data shows potential for companion diagnostic to the Pfizer-BioNTech COVID-19 vaccine
Omega Diagnostics Gp (ODX.L) AbC-19TM rapid antibody test performance data
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes
Omega Diagnostics Gp (ODX.L) Director/PDMR Shareholding
Director/PDMR Shareholding – Exercise of Options and Total Voting Rights
Omega Diagnostics Gp (ODX.L) UK Government contract and trading update
UK Government manufacturing contract Board appointment & trading update
Omega Diagnostics Gp (ODX.L) Update re AbC-19 Rapid Test & antibody test service launch
Update re AbC-19TM Rapid Test
Omega Diagnostics Gp (ODX.L) Update re AbC-19 Rapid Test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today’s update from Abingdon Health plc (AIM: ABDX)
